Chronic drinkers should avoid acetaminophen altogether if possible
HSA/FSA eligibility and the optional Precision Peptide Genetic Test ($99) help personalize your therapy based on genetic response patterns
Related articles Novo Nordisk Korea to launch smart insulin pen cap Novo Nordisk's Wegovy secures new indication for cardiovascular risk reduction in Korea Korean new obesity drugs showcased at ADA 2024 in US Drugmakers set out to secure GLP-1 analogs for obesity treatment Koreans lack awareness of crucial obesity indicator, survey reveals Obesity epidemic grips Korea: drugmakers rush to develop treatments How will Wegovy fit into obesity societys guidelines in Korea
In addition to the trial results released on April 27, a clinical trial published in the New England Journal of Medicine last year showed that patients who were obese or overweight and had other health conditions such as high blood pressure, high cholesterol, or cardiovascular disease lost 20% of their body weight in 16 months while taking the maximum dose of 15mg
Clinical studies indicate weight loss of 15-20% when combined with lifestyle changes, endorsing it as one of the most potent weight loss medications
The difference is small but measurable
